TSX Delisting Review - Bradmer Pharmaceuticals Inc. (BMR)

TORONTO, Feb. 5 /CNW/ - DELISTING REVIEW - Bradmer Pharmaceuticals Inc. (the "Company") - Further to TSX Bulletin No. 2009-0904 dated July 13, 2009, TSX has determined to delist the common shares (Symbol: BMR) of the Company at the close of market on March 5, 2010 for failure to meet the continued listing requirements of TSX.

    About TMX Group

TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tmx.com.

SOURCE Toronto Stock Exchange Reviews and Suspensions

For further information: For further information: Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, info@tsx.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890